Table 2 Comparison of SPP and ABI lower and higher group in HD patients
From: Skin perfusion pressure predicts mortality in hemodialysis patients: long term follow-up
SPP <70 | SPP ≥70 | ABI <1.15 | ABI ≥1.15 | ||||
|---|---|---|---|---|---|---|---|
(n = 22) | (n = 23) | p value | (n = 23) | (n = 22) | p value | ||
Gender (male to female) | 13:09 | 18:05 | Gender (male to female) | 15:08 | 16:06 | ||
Age (years) | 66.8 ± 14.5 | 58.7 ± 8.8 | 0.04 | Age (years) | 68.0 ± 11.4 | 57.7 ± 11.5 | 0.01 |
HD duration (years) | 8.1 ± 6.1 | 6.6 ± 4.0 | 0.32 | HD duration (years) | 8.3 ± 6.2 | 6.4 ± 3.9 | 0.56 |
DM, n (%) | 10 (59.0%) | 7 (41.0%) | 0.31 | DM, n (%) | 11 (64.7) | 6 (53.3) | 0.09 |
Current smoking, n (%) | 3 (60.0%) | 2 (40.0%) | 0.91 | Current smoking, n (%) | 4 (60.0%) | 1 (40.0%) | 0.91 |
Statin, n (%) | 3 (60.0%) | 2 (40.0%) | 0.65 | Statin, n (%) | 3 (60.0%) | 2 (40.0%) | 0.66 |
Cilostazol, n (%) | 3 (75.0%) | 1 (25.0%) | 0.46 | Cilostazol, n (%) | 3 (75.0%) | 1 (25.0%) | 0.44 |
Hb (g/dl) | 10.2 ± 1.0 | 10.0 ± 1.0 | 0.62 | Hb (g/dl) | 10.2 ± 0.9 | 10.0 ± 1.0 | 0.62 |
Alb (g/dl) | 4.1 ± 0.4 | 4.2 ± 0.3 | 0.39 | Alb (g/dl) | 4.1 ± 0.3 | 4.1 ± 0.5 | 0.39 |
BUN (mg/dl) | 68.5 ± 12.1 | 70.1 ± 12.5 | 0.65 | BUN (mg/dl) | 66.9 ± 12.4 | 71.6 ± 11.8 | 0.19 |
Cr (mg/dl) | 10.3 ± 1.9 | 12.0 ± 2.1 | 0.01 | Cr (mg/dl) | 10.8 ± 2.1 | 11.4 ± 2.2 | 0.38 |
P (mg/dl) | 4.9 ± 1.2 | 5.2 ± 1.2 | 0.43 | P (mg/dl) | 5.1 ± 1.1 | 5.1 ± 1.3 | 0.94 |
i-PTH (pg/dl) | 170.4 ± 93.5 | 182.0 ± 129.7 | 0.71 | i-PTH (pg/dl) | 213.1 ± 134.8 | 142.3 ± 74.4 | 0.03 |
LVDd (mm) | 50.5 ± 5.1 | 51.8 ± 5.1 | 0.41 | LVDd (mm) | 50.9 ± 4.7 | 51.4 ± 5.4 | 0.71 |
LVEF (%) | 64.6 ± 7.1 | 68.5 ± 10.2 | 0.15 | LVEF (%) | 64.6 ± 9.3 | 68.6 ± 8.4 | 0.14 |